Synapses are the microprocessors of the mind that encode and store memories. In Alzheimer’s disease (AD), synapses are damaged by the constituents of abnormal beta-amyloid plaques that accumulate in the brain. Indeed, the loss of synapses correlates most closely with cognitive decline in people with AD. Currently, no treatments are available to prevent or slow the progression of AD.
This PhD project will initiate a collaborative project within the Astbury Centre for Structural Biology, University of Leeds between the research groups of Dr René Frank, Professor Sheena Radford FRS OBE and Dr Eric Hewitt. The aim of the project is to determine the in situ 3D molecular structures associated with AD to understand disease mechanisms and molecular pathways that can lead to the rational design of a mechanism-based therapy. To this end, we have developed methods combining mouse genetics and cryo-electron microscopy (cryoEM).
The methods used will include: i) Electron tomography and computational image processing. ii) experiments with mouse models of Alzheimer’s disease iii) Biochemical and genetic labelling. Applicants from all backgrounds, including physical, chemical and biological sciences, are encouraged to apply. Some experience with programming (e.g. Python, Matlab or similar) will be highly advantageous.
This project will generate information-rich molecular structures of the mammalian brain that are expected to provide new insights into disease mechanisms. Thus, the student undertaking this research will receive an interdisciplinary training at the cutting edge of structural biology, neuroscience, and dementia research.
Prospective PhD students are encouraged to send an informal email enquiry to Dr René Frank in the first instance with a summary of what interests you about our research and any laboratory or computational experience to date. Please also attach your CV.
Benefits of being in the DiMeN DTP:
This project is part of the Discovery Medicine North Doctoral Training Partnership (DiMeN DTP), a diverse community of PhD students across the North of England researching the major health problems facing the world today. Our partner institutions (Universities of Leeds, Liverpool, Newcastle and Sheffield) are internationally recognised as centres of research excellence and can offer you access to state-of the-art facilities to deliver high impact research.
We are very proud of our student-centred ethos and committed to supporting you throughout your PhD. As part of the DTP, we offer bespoke training in key skills sought after in early career researchers, as well as opportunities to broaden your career horizons in a range of non-academic sectors.
Being funded by the MRC means you can access additional funding for research placements, international training opportunities or internships in science policy, science communication and beyond. See how our current DiMeN students have benefited from this funding here: http://www.dimen.org.uk/overview/student-profiles/flexible-supplement-awards
Further information on the programme and how to apply can be found on our website:
The information you submit to University of Leeds will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.
Based on your current searches we recommend the following search filters.
Check out our other PhDs in Leeds, United Kingdom
Check out our other PhDs in Genetics
Start a new search with our database of over 4,000 PhDs
Based on your current search criteria we thought you might be interested in these.
MRC DiMeN Doctoral Training Partnership: Neuroinflammation in Alzheimer’s disease: what is the role of amyloid-beta fibril structure?
University of Leeds
MRC DiMeN Doctoral Training Partnership: Two diseases, one brain: The effects of cardiovascular disease on the speed, progression and severity of Alzheimer’s Disease.
University of Sheffield
MRC DiMeN Doctoral Training Partnership: Use of 3D skin models and patient-derived immune cells to elucidate the molecular mechanisms of skin detachment in severe drug-induced skin adverse reactions
University of Liverpool